CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Finland
Summary
GlobalData, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Finland. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Finland. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Finland. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.
Finland is one of the rapidly emerging markets in the EU, with a strong focus on pharmaceutical R&D. It spends approximately 9.4% of its GDP on healthcare. The pharmaceutical market value decreased from $2.50 billion in 2010 to $2.47 billion in 2015 at negative CAGR of 0.26%, owing to an increase in generic volume from 34% in 2010 to 42% in 2015. It is expected to reach $2.65 billion in 2022. However, the market value in terms of Euros was €1.89 billion in 2010 and increased at a CAGR of 3% from 2015. It is expected to reach €2.80 billion in 2022. The Finnish medical device market was valued at $0.99 billion in 2010, which increased to $1.27 billion in 2017. The main segments were cardiovascular devices, diabetes care devices, in vitro diagnostics, orthopedic devices and ophthalmic devices. The increasing elderly population, favorable foreign investment environment and tremendous innovation are expected to drive the growth of the pharmaceutical market. However, generic substitution, increased healthcare expenditure and presence of counterfeit medicines act as a major barrier for the pharmaceutical market.
Scope
The report provides information on the healthcare, regulatory, and reimbursement landscape in Finland, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Pfizer, GSK, Sanofi and Orion) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche, DePuy, Zimmer Biomet and Revenio)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Finland
- Porter’s five forces analysis for pharmaceutical and medical devices market of Finland
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Finnish healthcare market.
Reasons to buyThis report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Finnish healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Finnish healthcare market.
- Executive Summary
- Overview of Pharmaceutical Market
- Overview of Medical Device Market
- Deals Analysis
- Porter’s Five Forces Model
- Market Access
- Country Healthcare Landscape
- Opportunities and Challenges
- Appendix
- List of Tables
- Table 1: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class ($m), 2016
- Table 2: Pharmaceutical Market, Finland, Sales of Major Drug Categories by Major Therapeutic Class ($m), 2016
- Table 3: Medical Device Market, Finland, Revenue by Segment
- Table 4: Cardiovascular Devices Market, Finland, Revenue and Market Share of Major Players
- Table 5: Diabetes Care Devices Market, Finland, Revenue and Market Share of Major Players
- Table 6: In Vitro Diagnostics Devices Market, Finland, Revenue and Market Share of Major Players
- Table 7: Orthopedic Devices Market, Finland, Revenue and Market Share of Major Players
- Table 8: Ophthalmic Devices Market, Finland, Revenue and Market Share of Major Players
- Table 9: Reimbursement for Medical Expenses, Finland
- Table 10: Exceptional Copayment Rate for Specific Medicines, Finland
- Table 11: Market Authorization Fees, 2017, Finland
- Table 12: Patent Fees, 2017, Finland
- Table 13: Pharmacy Tax for a Pharmacy Owning a Subsidiary Pharmacy
- Table 14: Package Label Information, Finland, 2017
- Table 15: Trade Associations, Finland
- Table 16: Trade Fairs, Finland
- List of Figures
- Figure 1: Pharmaceutical Market, Finland, Revenue, 2010-2017
- Figure 2: Medical Device Market, Finland, Revenue, 2010-2017
- Figure 3: Total Generics Sales (by value), Finland, (%), 2015
- Figure 4: Number of Deals (2017-2018)
- Figure 5: 2017-2018 Deal Overview By Region
- Figure 6: Country Profile, Finland, 2018
- Figure 7: Pharmaceutical Market, Finland, Revenue, 2010-2017
- Figure 8: Pharmaceutical Market, Finland, Revenue Forecast, 2018-2022
- Figure 9: Pharmaceutical Market, Finland, Pharmaceutical Exports
- Figure 10: Pharmaceutical Market, Finland, Top Export Partners
- Figure 11: Pharmaceutical Market, Finland, Pharmaceutical Imports
- Figure 12: Pharmaceutical Market, Finland, Top Import Partners
- Figure 13: Pharmaceutical Market, Finland, Supply Channels
- Figure 14: Pharmaceutical Market, Finland, Supply Channels, Pharmacies
- Figure 15: Pharmaceutical Market, Finland, Sales of Patented Drug Products by Major Therapeutic Class, 2016
- Figure 16: Pharmaceutical Market, Finland, Major Players
- Figure 17: Medical Device Market, Finland, Revenue, 2010-2017
- Figure 18: Medical Device Market, Finland, Revenue Forecast, 2018-2022
- Figure 19: Medical Device Market, Finland, Revenue by Segment, 2017
- Figure 20: Cardiovascular Market, Finland, Revenue
- Figure 21: Cardiovascular Market, Finland, Market Share of Major Players
- Figure 22: Diabetes Care Devices Market, Finland, Revenue
- Figure 23: Diabetes Care Devices Market, Finland, Market Share of Major Players
- Figure 24: In Vitro Diagnostics Devices Market, Finland, Revenue
- Figure 25: In Vitro Diagnostics Devices Market, Finland, Market Share of Major Players
- Figure 26: Orthopedic Devices, Finland, Revenue
- Figure 27: Orthopedic Devices, Finland, Market Share of Major Players
- Figure 28: Ophthalmic Devices Market, Finland, Revenue
- Figure 29: Ophthalmic Devices Market, Finland, Market Share of Major Players
- Figure 30: Diagnostic Market, Finland, Revenue ($bn), 2010-2017
- Figure 31: Diagnostic Market, Finland, Revenue Forecast ($bn), 2018-2022
- Figure 32: Medical Device Market, Finland, Revenue of Major Players
- Figure 33: Deal Value and Deal Count, Pharmaceutical Market, Finland, 2017-2018
- Figure 34: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Finland, 2017
- Figure 35: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Finland, 2017-2018
- Figure 36: Top Five Therapy Area by Deal Value, Pharmaceutical Market, Finland, 2017-2018
- Figure 37: Top Five Therapy Area by Deal number, Pharmaceutical Market, Finland, 2017-2018
- Figure 38: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Finland, 2017-2018
- Figure 39: Medical Device Market Deals, Finland, 2017-2018 (by deal value, $m)
- Figure 40: Medical Device Market Deals, Finland, 2017-2018 (by deal count)
- Figure 41: Medical Device Market Deals Share (by deal count), Finland, 2017-2018
- Figure 42: Medical Device Market Deals Share (by deal value), Finland, 2017-2018
- Figure 43: Top Therapy Area by Deal Value, Medical Device, Finland, 2017-2018
- Figure 44: Top Therapy Area by Deal Number, Medical Device, Finland, 2017-2018
- Figure 45: M&A Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number)
- Figure 46: Venture Financing Deals by Therapy Area, Medical Device, Finland, 2017-2018 (by value and by number)
- Figure 47: Private Equity Deals by Therapy Area, Medical Device Finland, 2017-2018 (by value and by number)
- Figure 48: Healthcare System, Finland
- Figure 49: Reimbursement Process, Finland
- Figure 50: Medical Reimbursement System, Finland
- Figure 51: Out-of-Pocket Expenditure (% of total expenditure on health)
- Figure 52: Annual Rate of Change (%), Health Price Index, Finland
- Figure 53: FIMEA, Organizational Structure, Finland
- Figure 54: Life Cycle of Outpatient Medicine, Finland
- Figure 55: Centralized Procedure, 2017, Finland
- Figure 56: Decentralized Procedure, 2017, Finland
- Figure 57: Mutual Recognition Procedure, 2017, Finland
- Figure 58: Life Cycle of Medical Devices, Finland
- Figure 59: Conformity Assessment of Class I Medical Devices, EU, 2017
- Figure 60: Conformity Assessment of Class IIa Medical Devices, EU, 2017
- Figure 61: Conformity Assessment of Class IIb Medical Devices, EU, 2017
- Figure 62: Conformity Assessment of Class III Medical Devices, EU, 2017
- Figure 63: European Patent Approval Process, EU, 2017
- Figure 64: Unitary Patent Approval Process, EU, 2017
- Figure 65: Trademark Approval Process, Finland, 2018
- Figure 66: Number of Hospitals, Finland, 2010-2017
- Figure 67: Diagnostic Equipment, Finland, 2010-2017
- Figure 68: Hospital Beds (per 1,000 population), Finland
- Figure 69: Acute Care Hospital Beds (per 1,000 population), Finland
- Figure 70: Psychiatric Hospital Beds (per 1,000 population), Finland
- Figure 71: Life Expectancy, 2010-2017, Finland
- Figure 72: Immunization Rate (%), 2010-2017, Finland
- Figure 73: PM2.5 (μg per m3), Finland, 2010-2016
- Figure 74: CO Emissions (million tons), Finland, 2010-2016
- Figure 75: Physicians (per 1,000 population), Finland, 2010-2016
- Figure 76: Nurses (per 1,000 population), Finland, 2010-2016
- Figure 77: Dentists (per 1,000 population), Finland, 2010-2016
- Figure 78: Pharmacists (per 1,000 population), Finland, 2010-2016
- Figure79: Major Causes of Mortality (per 100,000 population), Finland, 2015
- Figure 80: Major Causes of Male Mortality, Finland, 2015
- Figure 81: Major Causes of Female Mortality, Finland, 2015
- Figure 82: Disability-Adjusted Life Years by Major Disease (‘000), Finland, 2016
- Figure 83: Healthcare Expenditure as Percentage of GDP (%), Finland, 2010-2017
- Figure 84: Public-Private Share (%), Finland, 2010-2016
- Figure 85: Major Components of Healthcare Spending (%), Finland, 2016
- Figure 86: Opportunities and Challenges, Finland